(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

122018073776

Em AnáliseUtility ModelPCT · EP2013001504

Application data

Number

122018073776

Type

Utility Model

Filing

05/21/2013

Publication

-

PCT

EP2013001504

Progress at the INPI

  1. Filing05/21/13
  2. Publication
  3. Examination
  4. Refused04/18/23
  5. Grant
  6. In force

The application was refused on 04/18/2023 and the appeal did not change the decision. The invention was never patented and the technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/18/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ASTELLAS PHARMA INC.

JP

GANYMED PHARMACEUTICALS AG

DE

TRON - TRANSLATIONALE ONKOLOGIE AN DER JOHANNES GUTENBERT-UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBH

DE

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

111

Recorrente: O depositante. @Despacho: Recurso conhecido e negado provimento. Mantido o indeferimento do pedido. [111]

04/18/2023

RPI 2728

120

Recorrente: O depositante.@ Despacho: Tome conhecimento do parecer técnico e se manifeste no prazo de 60 (sessenta) dias. [120]

10/04/2022

RPI 2700

Petição de recurso

#12.2

Recurso: 870210039085 - 29/04/2021

05/11/2021

RPI 2627

Indeferimento

#9.2

03/02/2021

RPI 2617

Conhecimento de parecer técnico

#7.1

09/15/2020

RPI 2593

Transferência deferida

#25.1

01/21/2020

RPI 2559

Notificação de pedido dividido

#2.4

Dividido do PCT 11 2014 028948-4

02/12/2019

RPI 2510

Exigência - art. 21 da LPI

#2.5

Dividido do PCT 11 2014 028948-4

01/02/2019

RPI 2504

Requerimento de pedido de patente

#2.10

Número de Protocolo '870180152827' em 19/11/2018 16:21 (WB)

11/27/2018

RPI 2499

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.